1 Growth Stock Down Nearly 40% to Buy and Hold For 10 Years
The past three years have been a roller-coaster ride for investors, and such heightened volatility can sometimes make it hard to focus on the long term. But that is precisely the right move. If history is any indication, equity markets will be up substantially from their current levels in a decade. All investors have to do to cash in on that is buy shares of excellent companies and be patient.
On that note, let's consider one stock whose prospects through the next 10 years look attractive: Doximity (NYSE: DOCS). Here are three reasons why investing in this healthcare-focused networking platform is a good idea, even as its stock is down nearly 40% from a year ago.
Doximity runs a platform that allows physicians and others in the medical field to network, look for new job opportunities, catch up on the latest research, call patients for telemedicine visits, and much more. The company makes money primarily by charging subscription fees to pharmaceutical companies and hospitals that advertise their products and job opportunities on its platform.
Source Fool.com
